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ABSTRACTSIntroduction: Patient-centred care and patient satisfaction are increas-
ingly recognised as being integral to high quality urological care. However,
little evidence exists for whether the understanding experience of patients
reﬂects the perceptions of healthcare professionals. This study aimed to
explore urology patients' experience of the urology MDT.
Method: Focus groups were set up to explore qualitatively participants'
experiences and opinions. Questions covered patients' experience of
being treated by a urology-MDT, awareness of the MDT's role, informa-
tion the MDT should consider, and patient representation at MDT
meetings.
Results: Three focus groups were attended by 21 participants. Aware-
ness of the MDT was low, but participants found the idea reassuring.
Participants felt that it was important for the MDT to consider
psychosocial information and their preferences, although this was not
always their experience. Participants felt that the urology specialist
nurse should act as their advocate in the meeting and that case
discussion should be delayed if no one who had seen and knew the
patient was present.
Discussion: The concept of the MDT is popular with patients and could be
promoted to increase patient satisfaction and improve patient experience.
Further research is needed to link patients' MDT views with patient
outcome and experience measures.
0630: RELIABILITY OF TRUS CALCULATIONS OF PROSTATE VOLUME
Kaylie Hughes, David Ellis, Richard Stephenson. Wirral University Teaching
Hospital NHS Foundation Trust, Wirral, UK
Aim: Prostate size is an important parameter in the assessment and
treatment of prostate cancer. Prostate speciﬁc antigen (PSA) density can
inﬂuence investigation approach and volume limits are often included in
acceptance criteria for template biopsy and brachytherapy. We aim to
assess the accuracy of volumes calculated by trans-urethral ultrasound
(TRUS) compared with those from MRI.
Method: All patients in our hospital undergoing TRUS imaging and pros-
tatic biopsies were identiﬁed for the period of twelve months from
December 2010 to 2011. Our standard protocol for potential candidates for
curative therapy includes MRI quickly followed by TRUS biopsy. This allows
a reasonable timeframe for comparison. Sizes were calculated using the
standard ellipse method.
Findings: We identiﬁed 196 patients for whom MRI and TRUS volumes
were documented within six weeks of each other. Results were compared
with a Wilcoxon-signed rank test. No signiﬁcant difference was identiﬁed
(p¼0.108).
Conclusion: Our results suggest that MRI prostate offers no added beneﬁt
when it comes to measuring prostate size. We feel that consistency
between volumes produced by different imaging modalities is more
important than absolute precision, as any thresholds will have been
derived from the same methods.
0646: IS THE FREE/TOTAL PSA RATIO USEFUL AT PREDICTING THE
PRESENCE OF PROSTATE CANCER ON TRANSPERINEAL PROSTATE
MAPPING BIOPSIES?
Neil Kotecha, Shahid Aziz Anwar Khan, A.M Emara, S.R.J. Bott, R.G
Hindley. Hampshire Hospital, Basingstoke, UK
Aim: We evaluated the role of Free/Total (F/T) PSA ratio in improving the
prediction of prostate cancer in the transperineal prostate mapping biopsy
(TPM) setting.
Methods: The F/T PSA ratiowere available in 145 patients with a total PSA<
20ng/ml. All patients underwent a standard TPM under GA. The cancer
detection rate, pathologic features of the cancers detected, and the prob-
ability of cancer detection in relation to the F/T PSA ratio were estimated.
Results: Mean Age and PSA were 64.4 years and 9.5ng/l respectively
(Range 1.6-20ng/ml). Overall cancer detection rate was 51.8%. 55/145 had
a F/T ratio < 10 % of which 34/55 (61.8%) conﬁrmed cancer (n¼10 had
Gleason 7, n¼24 had Gleason 6). 66/145 had a F/T PSA ratio between 10-
20% with 50% of them having positive biopsies (n¼26 had Gleason 6, n¼38
had Gleason 7 and only 2 had Gleason 8). 24/145 had a F/T PSA ratio > 20%
and only 1/3 had evidence of cancer (all Gleason 6).
Conclusion: The F/T PSA ratio in our series failed to confer a signiﬁcant
beneﬁt in improving the cancer detection rate. However, in patients with
a ratio of >20% only 1/3 had cancer present but were of a favourable grade.0682: FEASIBILITY OF RANDOMISATION IN THE RANDOMISED
CONTROLLED TRIAL OF OPEN, ROBOTIC AND LAPAROSCOPIC (CORAL)
RADICAL CYSTECTOMY TRIAL
Grace Cheung, Amit Patel, Fahim Ismail, Peter Rimmington, Shamim
Khan, Prokar Dasgupta. Guy's Hospital, London, UK
Introduction: Minimally-invasive techniques for radical cystectomy are
increasing in prevalence in the urological community. However, current
evidence is lacking in which surgical technique is best.
Methods: A single-centre randomised-controlled trial comparing open,
laparoscopic and robotic-assisted radical cystectomy (RARC) for muscle-
invasive or high-grade bladder cancer is currently underway at our centre, to
investigate the short and long-term outcomes for each of these techniques.
Results: 83 patients were eligible to be enrolled in the trial since March
2009. 54 patients agreed to participate.
There was no difference between the trial and non-trial patients in terms
of age (<70 years compared with > 70 years, p¼0.8), gender or body mass
index (BMI) (BMI<25 compared with BMI > 25, p¼0.5).
Of the non-trial patients, 13 chose open cystectomy and 16 chose RARC.
None in this group chose the laparoscopic technique.
Conclusion: The majority of eligible patients agreed to random allocation,
and there appears to be no difference between non-trial participants
towards choosing an open or robotic approach. There is no obvious
selection bias in terms of age, gender or BMI for randomisation in this trial.
0704: LAPAROSCOPIC NEPHRECTOMY IN PATIENTS WITH BENIGN
RENAL DISEASE AND ITS EFFECT ON HYPERTENSION
Anna Mainwaring, Ninaad Awsare, Neil Fenn. Morriston Hospital, Swansea,
UK
Aim:We investigated the safety and efﬁcacy of laparoscopic nephrectomy
(LN) in the treatment of refractory hypertension in patients with a unilat-
eral poorly functioning kidney.
Method: A retrospective review of patients undergoing laparoscopic simple
nephrectomy for benign disease between 2005 and 2011 was performed
using information from hospital and general practice patient records,
operating theatre and pathology databases. 49 patients underwent LN for
the following indications: (n¼13) difﬁculty controlling hypertension, (n¼20)
chronic renal pain, (n¼11) recurrent urinary tract infection and (n¼5) had
both pain/infection. Data collected included operative details, complications
recorded using the Clavien Classiﬁcation and symptom control.
Results: All procedures were completed laparoscopically with no open
conversions. There was no change in post operative creatinine levels.
Complications occurred in 10(20%) patients with Clavien Classiﬁcation as;
Grade 1:(4) patients; Grade 2:(4) patients, Grade 3b:(1) patient, Grade
4:(1) patient. In the hypertension group therewas no immediate reduction
in post-operative blood pressure, however on follow up 2(15%) stopped all
antihypertensive medication, 6(46%) reduced their medication with no
change in 5(39%) patients.
Conclusions: Laparoscopic nephrectomy for symptomatic benign renal
disease is safe. The high success rate in reduction of antihypertensive
medication conﬁrms its efﬁcacy and provides useful information when
counselling patients preoperatively.
0716: THE SURGICAL CARE PRACTITIONER – ASSISTING, NOT
COMPETING WITH, THE EXPERIENCED REGISTRAR AS PART OF
MODULAR TRAINING FOR OPEN RADICAL RETROPUBIC-
PROSTATECTOMY
James Osborne, Jaspal Phull, Jim Wilson, Adam Carter. Royal Gwent
Hospital, Newport, UK
Aim: Open radical retropubic-prostatectomy (RRP) requires both an
experienced surgeon and assistant. We compare a Surgical Care Practi-
tioner (SCP) as primary assistant against an experienced SpR (Syear4)
assistant. We test the feasibility of using a SCP as assistant to a senior SpR
in RRP by comparing their respective outcomes as ﬁrst assistant.
Methods: Retrospective review of all RRPs between January 2010 and
October 2011. The ﬁrst assistant was recorded (SCP or SpR). Outcomes
were (1) intra-operative re-transfusion volume, (2) post-operative hae-
moglobin drop, and (3) operating time.
Results: 99 RRPs were identiﬁed. 91 cases were suitable for analysis. The
ﬁrst assistant was the SCP in n¼55 and Year 4/5 SpR in n¼36.
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ABSTRACTSBetween the SCP and SpR groups therewas no difference in (1) mean intra-
operative re-transfusion (598ml vs 636ml p¼0.44), (2) mean post-opera-
tive haemoglobin drop (2.32g/dl vs 2.29g/dl, p¼0.92), and (3) mean
operating time (137.9min vs 141.7min, p¼0.57).
Conclusions: As an assistant, there is no difference between the SCP and
SpR. Our data supports using the SCP as an experienced ﬁrst assistant to
the experienced SpR for training.
0723: SURGICAL OUTCOMES OF NEPHRON SPARING SURGERY FOR
RENAL TUMOURS
Anna Mainwaring, Ninaad Awsare, Pradeep Bose, Neil Fenn, Jonathan
Featherstone. Morriston Hospital, Swansea, UK
Aim: Nephron sparing surgery (NSS) is increasingly being performed to
treat renal tumours. We reviewed our surgical outcomes following partial
nephrectomy.
Methods:A retrospective reviewof 51 consecutive patients (median age 59
years) undergoing NSS for renal tumours between 1999 and 2011. Indica-
tions for NSSwere absolute (n¼14), relative (n¼16) or elective (n¼21). Data
collected included peri-operative, histological, disease-free and overall
survival data. Complicationswere recorded using the Clavien classiﬁcation.
Results: Most procedures were performed open (n¼46). More recently
selected cases have been performed laparoscopically (n¼5). There were no
peri-operativedeathsandnopatients required renaldialysis. Sixteenpatients
(31%) had post-operative complications. Of these, 8 were Grade 1, 5 were
Grade2 and3wereGrade 3aaccording to theClavien classiﬁcation.Histology
conﬁrmed 37(73%) tumours were malignant and 14(27%) were benign.
During follow up there were no local recurrences, but 1 patient (3%) devel-
opedmetastatic disease. The overall survival rate at amedian follow up of 31
monthswas 92%with only one death attributable tometastatic renal cancer.
Conclusion: NSS for renal tumours is safe with an acceptable peri-oper-
ative morbidity rate. Preservation of renal function and low recurrence
rates conﬁrm it is an effective treatment option.
0755: CAN URINE CYTOLOGY BE SAFELY OMITTED FROM ROUTINE
WORK-UP FOR HAEMATURIA?
Eleni Anastasiadis 2, Dhili Arul 1, Kara Bruce-Hickman 1, Sudhanshu
Chitale 1, M. Ghei 1, Barry Maraj 1. 1Whittington Health, London, UK; 2 St
George's Healthcare Trust, London, UK
Introduction / Aim: Urine cytology has traditionally been part of routine
work-up for patients with haematuria but provided relatively limited
diagnostic yield at a signiﬁcant cost. We audited our practice in the local
setting to assess the value of urine cytology and the implications of
deleting it from the investigative pathway.
Method: Clinical data for 191 patients referred for urine cytological
examination over a period of 3 months (July – September 2010) was
collected from the hospital database.
Results: Haematuria was the presentation in 138 (73%) of these requests.
69% (95/138) were from Urologists. Of the 138, 77% were reported normal,
4% revealed atypical cells, 3% had malignant cells, 8% had appearances
indicative of inﬂammatory pathology and 8% were unsuitable for analysis.
Positive yield was < 10%. Of the 7% (9/138) with proven urothelial cancer
(only of bladder in this series), cytology was normal in 44%, atypical in 11%,
and malignant in 33%, highlighting that cytology would have missed
cancer in >50% of haematuria cases.
Conclusion: Urine cytology has very poor sensitivity for diagnosing uro-
thelial cancer, and the cost and effort to conduct this investigation does not
justify its use in the routine work-up of patients with haematuria.
0769: INCIDENTAL SYNCHRONOUS PRIMARY TUMOURS DETECTED
DURING A MODIFIED MRI PROSTATE PROTOCOL
Paul Hughes, Rajesh Nair, Tim Larner. Brighton and Sussex University
Hospitals NHS Trust, Brighton, UK
Introduction: Magnetic resonance imaging (MRI) is the cross-sectional
imaging modality of choice in staging prostate cancer. Standard protocol
for prostate MRI is limited to the pelvis. We describe beneﬁts of extended
MRI protocols in identifying incidental synchronous primary lesions,
which potentially inﬂuence prostate cancer management.
Patients & Methods: A retrospective single-center review of 464 patients
(median age 68, range 47-82 years) with a diagnosis of prostate cancerbetween January 2008 and December 2011 was performed. Outcomes
were reviewed in patients that underwent extended-MRI staging inwhom
synchronous abdominal and pelvic masses were identiﬁed.
Results: Eight patients had synchronous lesions identiﬁed: one adrenal
mass, one rectal cancer, two bladder cancers and four renal masses. The
adrenal mass was a non-functioning adenoma and one renal mass was
identiﬁed as a simple cyst. The remaining six cases (1.3%) had conﬁrmed
synchronous malignancies. In two patients this did not inﬂuence prostate
cancer management. The patients with rectal cancer and muscle invasive
bladder cancer would have been identiﬁed with conventional protocols.
The two patients with advanced renal malignancy were identiﬁed due to
extended MRI.
Conclusion: Signiﬁcant renal lesions were identiﬁed on extended-MRI
staging protocols for prostate cancer. These synchronous malignancies
potentially inﬂuence prostate cancer management.
0772: THE ROLE OF CONTRAST ENHANCED ULTRASOUND IN THE
ASSESSMENT OF COMPLEX OR EQUIVOCAL RENAL LESIONS
Paul Hughes, Rajesh Nair, Emma Simpson, Tim Larner. Brighton and Sussex
University Hospitals, Brighton, UK
Introduction: Contrast enhanced computed tomography (CECT) remains
the standard imaging modality for renal lesion characterisation. Circum-
stances however, exist where diagnostic uncertainty remains. Contrast
enhanced ultrasound (CEUS) is a safe, affordable, non-ionising adjunct in
the assessment of difﬁcult renal lesions. We describe our experience with
this emerging radiological technique.
Material andMethods:A single-centre retrospective reviewof 21 patients,
median age of 68 years (range 35-89 years) with equivocal renal lesions
was performed. All patients underwent CEUS using sonovuemicro-bubbles
between November 2010 and August 2011. Renal lesion enhancement,
clinical outcomes and histological correlation were analysed.
Results: In six patients with complex cystic renal lesions, three demon-
strated concerning enhancement. In thirteen cases with equivocal solid
lesions, nine were suggestive of renal cell carcinoma (RCC) of which ﬁve
underwent nephrectomy. Three lesions demonstrated no enhancement.
Only in one case was a lesion felt to be equivocal necessitating further
imaging. Two cases were post-cryotherapy ablation, of which one
demonstrated recurrence not accessible on CECT. CEUS aided clinical
decision-making in 90% (19/21) of cases.
Conclusion: CEUS is an important adjunct to conventional imaging in
delineating the nature of complex renal lesions, particularly those with
renal impairment, when contrast agents are contra-indicated.
0797: THE IMPORTANCE OF THE BIOPSY OF NORMAL APPEARING
BLADDER MUCOSA AT THE EDGE OF PRIMARY TUMOUR RESECTION
SITE
Asheesh Kaul, Chris Jacobs, Michal Sut, Aasem Chaudry. Bedford Hospital
NHS Trust, Bedford, UK
Introduction: European Association of Urology guidelines advocate
separate biopsy of tumour base and edge during initial transurethral
resection of bladder tumour (TURBT). Most evidence available analyse the
prognostic value of random bladder biopsies rather than edge of resection
site speciﬁcally.
Aim: To evaluate the incidence and signiﬁcance of positive tumour edge
biopsies at primary TURBT.
Methods: 22 cases of primary TURBT performed between October 2010
and October 2011 were retrospectively reviewed. All resections included
a routine cold-cup biopsy of macroscopically normal mucosa at the
resection edge. Data sources included histopathology reports and Multi-
disciplinary Team Meeting notes.
Results: Abnormal biopsy was found in 9 patients (41%). Carcinoma-in-
situ (CIS) was found in 7 patients (32%) and in 2 cases (9%) biopsy results
were corresponding with primary pathology indicating incomplete
tumour resection.
Tumour edge biopsy effected management of 3 cases (22%). 2 patients (9%)
with CIS received intravesical chemotherapy with Bacillus Calmette-Gue-
rin (BCG) vaccine and 1 patient with incomplete resection underwent early
check cystoscopy and biopsy within 3 weeks of primary resection. Those
patients would otherwise have been scheduled for check cystoscopy at 3
months.
